Pharmaceutical manufacturer Novo Nordisk recently announced it will extend its 340B contract pharmacy restrictions to federal grantees.

News Alert

Novo to Extend Contract Pharmacy Restrictions to Grantees But Allow Them to Keep Access Under Conditions; Company Also Modifies Hospital Policy

Drugmaker Novo Nordisk this week announced that its contract pharmacy restrictions will soon apply to all grantee covered entities—not just [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at